Venous leg ulcers are common and distressing, affecting around 1 in 300 adults in the UK. They are open, often painful, sores on the leg that take months to heal and can develop after a minor injury.

Treating leg ulcers within two weeks by closing faulty veins improves healing by 12 per cent compared to standard treatment, according to new findings. The research, led by Imperial College London and ...

Treating leg ulcers within two weeks by closing faulty veins improves healing by 12 percent compared to standard treatment, according to new findings. The research, led by Imperial College London and ...

Venous leg ulcers are common and distressing, affecting around 1 in 300 adults in the UK. They are open, often painful, sores on the leg that take months to heal and can develop after a minor injury.

When compared with normal care, treating a leg ulcer with dressings impregnated with honey did not significantly improve the rate of healing, but did lead to a significantly increased number of ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the successful completion of its second Phase II clinical trial, ...

The medical technologies advisory committee considered evidence on compression products for treating venous leg ulcers. Evidence was considered from several sources to determine whether price ...

How do we prevent and treat venous stasis ulcers in our facility? Venous stasis ulcers are the most common wound found on the lower extremities and can be a challenge to prevent and treat. Risk ...

The committee concluded that the EXPLORER study provided convincing evidence that UrgoStart dressings improve complete wound healing in patients with diabetic foot ulcers. It noted the external ...

Venous ulcers are the most common type of leg ulcers, but that doesn't make them any less troubling. Most often found just above the ankle, these non-healing skin wounds can take on many shapes and ...

Polarityte Inc., of Salt Lake City, reported positive results from a pilot study of its Skinte regenerative skin product in the closure of venous stasis leg ulcers (VLUs) after standard treatments ...

POMPANO BEACH, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of ...